A 58-year-old Japanese man developed discomfort of his left neck, gradually increasing left chest pain, and weight loss (15 kg over six months). His primary physician noted generalized lymphadenopathy, and a neck lymph node was excised for diagnosis. When he was admitted to our hospital, he had severely decreased appetite accompanied by a large intra-abdominal mass. The lymphadenopathy was temporarily reduced by CHOP (cyclophosphamide, hydroxydoxorubicin/adriamycin, vincristine/oncovin, prednisone) chemotherapy, but pancytopenia and hepatomegaly persisted. After 3 courses of therapy, tumor cell regrowth was evident in peripheral blood and bone marrow and his course rapidly declined, with complications from hemophagocytic syndrome. He expired after a total course of 6 months. A postmortem examination was performed 2 hours after death. A final diagnosis of interdigitating cell sarcoma was made based on histological and immunohistochemical analyses of the biopsied lymph nodes and autopsy materials. His clinical course was extremely aggressive, and chemotherapy was not effective. Discussion of this case provides important insight into the clinicopathological features and treatment of this neoplasm.
INTRODUCTION
Interdigitating cells (IDCs) are a type of dendritic cell, which reside in T-cell dependent areas of lymphoid tissues and are essential for initiation of a variety of immune responses [1] [2] [3] . Because tumors derived from dendritic cells are relatively rare, their general clinicopathological features, including the degree of biological aggressiveness and applicable treatment, have yet to be characterized. Recently, an increased number of cases of this type of tumor have been reported , in part due to increased recognition by pathologists and improved identification of dendritic cells and their neoplastic counterparts by new antibodies specific to human dendritic cells. In the new WHO histological classification of tumors of hematopoietic and lymphoid tissues (published in 2001) 31 , dendritic cell tumors were classified as an independent category termed "histiocytic and dendritic cell neoplasms." We present here a case of a dendritic cell tumor with an aggressive clinical course.
CASE REPORT
A 58-year-old Japanese man, with a 10 year history of diabetes mellitus, complained of 2 months of discomfort of the submandibular portion of his left neck. He subsequently noted increasing left sided chest pain and malaise. His body weight decreased remarkably (15 kg over 6 months). His primary physician detected generalized lymphadenopathy and referred him to a general hospital for further examination and appropriate treatment. His family history was unremarkable.
On admission to the general hospital, mild anemia was detected (RBC 367 × 10 4 / μ l, Hb 12.2 g/dl), but his WBC (6,100/ μl) and platelet (24.7 × 10 4 / μl) counts were within the normal range. His peripheral blood differential included 47.0% neutrophils, 33.8% lymphocytes, 12.6% monocytes, 5.9% eosinophils, and 0.5% basophils. No atypical lymphocytes were identified. The serum soluble interleukin-2 receptor (sIL-2R) concentration was extremely high (2,230 U/ml). Other laboratory data including total protein (8.8 g/dl), albumin (3.7 g/dl), γ -globulin (46.1%), GOT (34 IU/l), GPT (17 IU/l), LDH (390 IU/l), ALP (314 IU/l), BUN (12.2 mg/dl), creatinine (0.8 mg/dl), and C-reactive protein (0.68 mg/dl) were within the normal range.
Lymphadenopathy of up to 3 cm in diameter of the superficial lymph nodes (LNs) in his left neck and inguinal region was objectively apparent. One of left neck LNs was excised for pathological examination. Mild hepatomegaly was also noticed. On computed tomography, enlarged neck, axillary, and para-aortic lymph nodes and hepatosplenomegaly were recognized. Gallium scintigraphy demonstrated multiple hot lesions in bilateral neck, right axillary, para-aortic, and mesenteric nodes. 99 mTc bone scintigraphy did not reveal any abnormal accumulation.
When he arrived at our hospital, his performance status according to the Eastern Cooperative Oncology Group (ECOG) scale 32 was level 4. He complained of severely decreased appetite accompanied by the presence of a large intra-abdominal mass. After the first course of chemotherapy with CHOP (cyclophosphamide, hydroxydoxorubicin/adriamycin, vincristine/oncovin, predonisone), his lymphadenopathy was temporarily reduced and his performance status improved to level 2. However, after the third course of chemotherapy, he rapidly developed pancytopenia, severe hepato-splenomegaly, and tumor cell involvement of the bone marrow and peripheral blood. He declined clinically and died after a total course of 6 months. A postmortem examination was performed 2 hours after his death.
MATERIALS AND METHODS
Tissue specimens obtained from neck lymph node biopsy and autopsy were fixed in 10% formalin, and conventional 4 μm thick paraffin sections were prepared. The sections were used for routine histological observation with hematoxylin and eosin staining and for immunohistochemical analysis using a labeled streptavidin-biotin method. The primary antibodies employed in the present analysis are listed in Table 1 . Briefly, deparaffinized tissue sections were immersed in either 0.1% trypsin (Difco, Franklin Lakes, NJ) in 0.01 M phosphate-buffered saline (PBS), pH7.4 with 0.15% CaCl2 for 30 minutes at 37°C or in 1 mM ethylenediamine tetraacetic acid solution, pH8.0 (EDTA, Muto Pure Chemicals, Tokyo, Japan) microwaved (400W) for 24 minutes at 90°C for antigenic retrieval. Endogenous peroxidase activity was quenched with methanol containing 0.3% hydrogen peroxide and nonspecific antibody binding was blocked with proteinblocking agent or skim milk. The slides were then incubated at 4°C overnight with the relevant primary antibodies. The labeled streptavidin-biotin/horseradish peroxidase (LSAB/ HRP) staining kit (DAKO, Glostrup, Denmark) was used. The reaction was developed with 3, 3 ′ -diaminobenzidine (Dojin Chemicals, Kumamoto, Japan) as a brown color. The sections were counterstained with hematoxylin.
Formalin-fixed, paraffin-embedded sections of tonsils obtained from 3 patients with chronic tonsillitis and lymph nodes from 3 patients with reactive lymphadenitis were used as specificity controls for the antibodies. As a negative control, non-immune rabbit or mouse immunoglobulins were used instead of the primary antibodies. In addition, control procedures were performed to determine the reactivity of the biotinylated secondary antibodies and peroxidase-conjugated streptavidin and to quantify endogenous peroxidase activity.
RESULTS

Microscopic findings in biopsied lymph nodes
Biopsied neck LNs were markedly enlarged, and their normal architecture was completely effaced by diffuse infiltration of tumor cells (Fig. 1a & 1b) . The morphology of the tumor cells was quite pleomorphic, frequently intermingled with a small number of non-neoplastic lymphocytes, plasma cells, eosinophils, and neutrophils. The majority of tumor cells were large with abundant pale or slightly eosinophilic cytoplasm. The nuclei were generally bean-shaped with irregular indentation and contained a few, small to moderately large nucleoli. Some tumor cells with a highly lobulated nucleus or multinucleated cells, with ring-like-arranged nuclei, were also seen. The number of mitotic figures ranged from 20 to 24 per 10 high-power fields. Fibrosis was not evident in the area where diffuse neoplastic cells infiltrated, but a thin fibrous capsule partially surrounded the tumor nodules. Erythrophagocytosis of the tumor cells was rarely observed.
Immunohistochemically, the majority of tumor cells were positive for fascin (55K-2), S-100 protein, vimentin, and CD74 (LN2) (Fig. 2a-2c ). CD68 (KP1)-and HLA-DR (LN3)-positive tumor cells were occasionally noted. No positive reactivity to CD1a (O10), CD3 (PS1), CD20 (L26), CD43 (DF-T1), or CD45 was observed. The MIB-1 (Ki-67) labeling index was 35 to 40%. The results of immunohistochemical labeling are summarized in Table 1 .
Autopsy findings
At autopsy, marked hepatomegaly (3,100g) due to extensive tumor cell infiltration was seen (Fig. 3a & 3b) . The tumor cells were highly pleomorphic and densely proliferating, predominantly in hepatic sinusoids. Splenomegaly (480g) was also detected with diffuse infiltration of pleomorphic tumor cells extending into the red pulp. In addition, tumor cells diffusely infiltrated into systemic LNs and bone marrow. The involved LNs were enlarged with complete effacement of the normal architecture, especially the mesenteric and retroperitoneal nodes which formed a conglomerated mass. Morphological and immunophenotypic features of tumor cells were similar to those in biopsied LNs. Skin involvement was not seen during his clinical course.
In spleen, bone marrow, and LNs, a large number of histiocytes, which had actively phagocytosed numerous erythrocytes, were seen among the tumor cells. These histiocytes were easily distinct from the tumor cells because they did not display nuclear atypia or immunoreactivity to the anti-S100 protein. This observation could be interpreted as evidence of reactive hemophagocytic syndrome (HPS). 31 . In contrast, histiocytes or mononuclear phagocytes primarily function in the removal of particulate antigens, dead cells, and cellular waste and are thought to be derived from the circulating blood monocyte pool. Histiocytic sarcoma or malignant histiocytosis is neoplastic counterparts of mononuclear phagocytes. Therefore, tumor cells show morphologic and immunophenotypic features similar to those of mature tissue histiocytes. As a result, they occasionally reveal phagocytic activity and express "histiocytic markers including CD68, lysozyme, CD11c, and CD14 31 . In the present case, the normal architectures of both of the biopsied neck LNs and systemic LNs from autopsy were completely effaced by a diffuse proliferation of tumor cells. -) was identical with that of previously reported neoplastic IDCs 25, 31 . Taken together with clinical and histopathological findings, the present tumor was compatible with IDC sarcoma arising from his neck or para-aortic LNs. The vast majority of the tumor cells were clearly positive for fascin, which is particularly important for identifying IDC or its neoplastic counterpart. Although expression of CD1a is variable among published cases of IDC sarcoma, the tumor cells in this patient did not display significant expression of the molecule 25, 31 . In this patient, significantly elevated serum sIL-2R was recognized. The serum concentration of sIL-2R is frequently increased not only in patients with malignant lymphoma 33 , but also in other tumors including lung 34 , ovarian 35 , colonic 36 and esophageal carcinomas 37 . Recently, several reports 35, 37 indicated that tumor cells can produce sIL-2R, even in nonlymphoid neoplasms. If specific antibodies or probes were available, further analysis would be expected to define which cells produce this receptor in the present case.
DISCUSSION
As described in the autopsy findings, numerous histiocytic cells, showing active phagocytosis of erythrocytes and other leukocytes, were observed among the tumor cells in lymph nodes, spleen, and bone marrow. These cells seemed to be reactive histiocytes rather than tumor cells because they obviously lacked nuclear atypia and reactivity to anti-S100 antibody, whereas they expressed intense CD68 reactivity. These findings indicated that reactive HPS complicated the IDC sarcoma at the terminal period of the disease. Thus far, although HPS has been described as associated with different types of neoplasms including T/NK-cell lymphoma 38 , B-cell lymphoma 39 , acute myeloid leukemia 40 , multiple myeloma 41 , and hepatocellular carcinoma 42 , there have been no reports on IDC sarcoma or related neoplasms accompanied by HPS.
To date, 42 cases of IDC sarcoma (Table 2 ) have been reported in the English literature, including our case. The clinicopathological features of these patients can be summarized as follows : 1) age ranged from 6 to 87 years, with an average of 48.74 years and a median of 55 years ; 2) lymph node-based diseases were frequent, while disease rarely arised from the spleen, skin, intestine, and oro-nasopharynx ; 3) secondary involvement of tumor cells in liver, bone marrow, and lungs was frequent. In 30 cases of IDC sarcoma with survival data, the average survival was 22.66 months and the median was 9.5 months ( Table 2) . Among these cases, 63.33% died within one year of disease onset, and 30% of cases died within 6 months. These data reveal that IDC sarcoma has the characteristics of a high-grade malignancy 43 . The following features of the present case may be predictive of an aggressive nature : 1) relatively early in the clinical period, the patient exhibited extensive involvement of tumor cells in the bone marrow, spleen, and liver, as well as systemic lymph nodes ; 2) histologically, the mitotic frequency (2 to 2.4/high power fields) and MIB-1 (Ki-67) labeling index (35-40%) were very high ; 3) complications from hemophagocytosis may hasten death 26 . Although rare cases of IDC sarcoma have been reported to be responsive to ABVD (adriamycin, bleomycin, vinblastine, dacarbazine) chemotherapy 27 , there exists no consensus on a standard chemotherapeutic regimen for this type of tumor. Most patients with this malignancy have been treated with chemotherapeutic regimens against non-Hodgkin's lymphomas. Responses to these regimens have been variable, but mostly unsuccessful. The different clinicopathological features of IDC sarcoma are not fully understood, but when individual cases are gathered and their clinicopathological characteristics are precisely analyzed in the future, useful information regarding the degree of biological aggressiveness and applicable treatment for this malignancy should be provided.
